4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-25-000004
Director sold 20,129 shares at $41.51 ($835,555)
- Director acquired 20,129 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Quart Barry D · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,129 | $10.36 | $208,536 | 32,675 | D |
| 2025-12-15 | Sale : show line 2 in the form 10b5-1 | −20,129 | $41.51 | $835,555 | 12,546 | D |
| Open-market sales · 20,129 sh · avg $41.51 · $835,555 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-15 | Exercise or conversion : show line 3 in the form 10b5-1 Share Option | −20,129 | 0 | D |
Loading xslF345X05/form4-12172025_091228.xml…